| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2002 ( Subtotal = $799,422 ) |
| | 2002 | 2002 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R01GM060915 | PARS AND PEROXYNITRITE INDUCED CELL DEATH | 000 | 4 | NIH | 7/1/2002 | $226,673 |
| | 2002 | 2002 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R01GM060699 | REGULATION OF NITRIC OXIDE IN HUMAN ENTEROCYTES | 000 | 4 | NIH | 4/19/2002 | $232,310 |
| | 2002 | 2002 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R43CA090016 | CANCER RADIOTHERAPY: SENSITIZATION BY INHIBITORS OF PAR* | 000 | 2 | NIH | 7/31/2002 | $205,022 |
| | 2002 | 2002 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R43DK059676 | ANTIDIABETIC EFFECTS OF INOSINE | 000 | 1 | NIH | 3/4/2002 | $135,417 |
|
| Issue Date FY: 2001 ( Subtotal = $970,896 ) |
| | 2001 | 2001 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R29GM054773 | POLY ADP RIBOSYLTRANSFERASE IN HEMORRHAGIC SHOCK | 000 | 6 | NIH | 4/19/2001 | $104,619 |
| | 2001 | 2001 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R43CA090016 | CANCER RADIOTHERAPY: SENSITIZATION BY INHIBITORS OF PAR* | 000 | 1 | NIH | 8/3/2001 | $205,022 |
| | 2001 | 2001 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R43NS042389 | (ADP-RIBOSE) SYNTHETASE INHIBITOR FOR MULTIPLE SCLEROSIS | 000 | 1 | NIH | 9/26/2001 | $215,515 |
| | 2001 | 2001 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R01GM060915 | PARS AND PEROXYNITRITE INDUCED CELL DEATH | 000 | 3 | NIH | 6/19/2001 | $220,155 |
| | 2001 | 2001 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219 | HAMILTON | USA | R01GM060699 | REGULATION OF NITRIC OXIDE IN HUMAN ENTEROCYTES | 000 | 3 | NIH | 4/4/2001 | $225,585 |
|
| Issue Date FY: 2000 ( Subtotal = $1,976,508 ) |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R21HL065145 | POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM | 000 | 2 | NIH | 9/7/2000 | $104,277 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R01GM060699 | REGULATION OF NITRIC OXIDE IN HUMAN ENTEROCYTES | 000 | 2 | NIH | 3/20/2000 | $219,056 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43HL065009 | PEROXYNITRITE AS MYOCARDIAL PROTECTIVE AGENTS | 000 | 1 | NIH | 6/12/2000 | $172,140 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43EY012920 | ADENOSINE 3 LIGANDS EXPERIMENTAL THERAPY OF UVEITIS | 000 | 1 | NIH | 2/29/2000 | $207,325 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43EY012921 | A NITRIC OXIDE SYNTHASE INHIBITOR FOR UVEITIS | 000 | 1 | NIH | 2/29/2000 | $213,065 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43DE013625 | NOVEL ANTIOXIDANTS FOR THERAPY OF PERIODONTAL DISEASE | 000 | 1 | NIH | 9/15/2000 | $160,215 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43HL064417 | ANTIOXIDANT EXPERIMENTAL THERAPY OF CIRCULATORY SHOCK | 000 | 1 | NIH | 8/21/2000 | $240,777 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R29GM054773 | POLY ADP RIBOSYLTRANSFERASE IN HEMORRHAGIC SHOCK | 000 | 5 | NIH | 8/10/2000 | $100,926 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R01GM060915 | PARS AND PEROXYNITRITE INDUCED CELL DEATH | 000 | 2 | NIH | 8/3/2000 | $213,829 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43DK057379 | ADENOSINE 3 RECEPTOR AGONIST FOR TREATMENT OF COLITIS | 000 | 1 | NIH | 1/31/2000 | $108,057 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43DK057336 | ORALLY ACTIVE INHIBITOR OF POLY (ADP) RIBOSE SYNTETHASE | 000 | 1 | NIH | 3/27/2000 | $125,493 |
| | 2000 | 2000 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R21DK057239 | POLY(ADP) RIBOSE SYNTHETASE AND AUTOIMMUNE DIABETES | 000 | 2 | NIH | 8/28/2000 | $111,348 |
|
| Issue Date FY: 1999 ( Subtotal = $6,065,489 ) (Continued on the next page) |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R01GM060699 | REGULATION OF NITRIC OXIDE IN HUMAN ENTEROCYTES | 000 | 1 | NIH | 3/31/1999 | $212,715 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43HL063526 | ANTI-INFLAMMATORY AGENT FOR SMOKE INHALATION & BURNS | 000 | 1 | NIH | 9/14/1999 | $114,237 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43HL062127 | VASODILATOR FOR NEONATAL PULMONARY HYPERTENSION | 000 | 1 | NIH | 4/14/1999 | $126,145 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43HL062759 | MERCAPTOETHYLGUANIDINE AND SICKLE CELL DISEASE | 000 | 1 | NIH | 5/10/1999 | $108,156 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R21HL065145 | POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM | 000 | 1 | NIH | 9/28/1999 | $117,190 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R21HL065145 | POLY RIBOSE SYNTHETASE & ENDOTHELIAL DYSFUNCTION IN IDDM | 000 | 1 | NIH | 9/28/1999 | $0 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43NS039216 | A NOVEL PEROXYNITRITE SCAVENGER COMPOUND | 000 | 1 | NIH | 9/2/1999 | $115,098 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43NS038396 | NOVEL PARS INHIBITOR FOR THE EXPERIMENTAL THERAPY OF PD | 000 | 1 | NIH | 5/4/1999 | $99,997 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43NS038397 | NOVEL NO SCAVENGER FOR THE EXPERIMENTAL THERAPY OF PD | 000 | 1 | NIH | 8/20/1999 | $100,000 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43NS037993 | TREATMENT OF ALLERGIC ENCEPHALOMYELITIS | 000 | 1 | NIH | 7/19/1999 | $99,996 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R44NS037642 | A NOVEL PARS INHIBITOR FOR THE THERAPY OF STROKE | 000 | 2 | NIH | 9/6/1999 | $1,123,640 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43GM059017 | XO INHIBITOR FOR THERAPY OF ACETAMINOPHEN INTOXICATION | 000 | 1 | NIH | 3/25/1999 | $47,006 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43GM059560 | TREATMENT OF ENDOTOXIC SHOCK WITH AN ADENOSINE 3 AGONIST | 000 | 1 | NIH | 8/17/1999 | $104,186 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R01GM060915 | PARS AND PEROXYNITRITE INDUCED CELL DEATH | 000 | 1 | NIH | 6/28/1999 | $210,019 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R29GM054773 | POLY ADP RIBOSYLTRANSFERASE IN HEMORRHAGIC SHOCK | 000 | 4 | NIH | 9/7/1999 | $99,335 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43GM058986 | ANIMAL TRIAL OF SEPTIC SHOCK WITH A NOVEL PARS INHIBITOR | 000 | 1 | NIH | 4/5/1999 | $100,000 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R01GM057407 | POLY (ADP-RIBOSE) SYNTHETASE IN SPLANCHNIC I-R INJURY | 000 | 2 | NIH | 12/24/1998 | $134,757 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R01HL059266 | MYICARDIAL INJURY: ROLE OF POLY (ADP-RIBOSE) SYNTHETASE | 000 | 2 | NIH | 3/29/1999 | $203,096 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R44DE012686 | A NOVEL AGENT FOR THE THERAPY OF PERIODONTAL DISEASE | 000 | 2 | NIH | 9/24/1999 | $1,257,680 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43DK055962 | NOVEL PARS INHIBITOR FOR ACETAMINOPHEN INTOXICATION | 000 | 1 | NIH | 8/23/1999 | $116,537 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R21DK057239 | POLY(ADP) RIBOSE SYNTHETASE AND AUTOIMMUNE DIABETES | 000 | 1 | NIH | 9/23/1999 | $120,259 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43DK055465 | PARS INHIBITOR FOR ISLET CELL TRANSPLANT REJECTION | 000 | 1 | NIH | 4/6/1999 | $99,998 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43AR046167 | TREATMENT OF ARTHRITIS WITH AN ADENOSINE-3 AGONIST | 000 | 1 | NIH | 9/10/1999 | $100,000 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43AR046397 | A NOVEL ANTI-INFLAMMATORY THERAPY FOR PSORIASIS | 000 | 1 | NIH | 9/24/1999 | $112,764 |
| | 1999 | 1999 | INOTEK, INC | 3130 HIGHLAND AVE, 3RD FLR | CINCINNATI | OH | 45219-2374 | HAMILTON | USA | R43DK054099 | NOVEL PARS INHIBITOR FOR THE THERAPY OF COLITIS | 000 | 1 | NIH | 4/9/1999 | $99,997 |
|
